Future studies could help elucidate the optimal timing of PSMA PET/CT during active surveillance, comparing PSMA-targeted biopsy to MRI-targeted biopsy, and the influence of PSMA PET/CT on the long-term oncological outcome of PCa patients on active surveillance. Here, FOLH1 is linked to posterior cortical atrophy.